Table 2.

The level of serum Cys-C in whole BUT patients.

Parameters	Number of patients	Cys-C	P
		levels (mg/L, mean ± SD)
Age			0.013
<60 yr.	167	0.95 ± 0.57
≥60 yr.	258	1.05 ± 0.31
Sex			0.704
Male	344	1.02 ± 0.45
Female	81	1.00 ± 0.37
Smoking history			0.153
Never	277	0.99 ± 0.30
Ever	148	1.05 ± 0.62
Painless macroscopic hematuria			0.928
No	89	1.00 ± 0.34
Yes	336	1.01 ± 0.46
WBC counta			0.553
<6.1 × 109/L	209	1.03 ± 0.56
≥6.1 × 109/L	216	1.00 ± 0.27
PLT counta			0.525
<213 × 109/L	212	1.03 ± 0.33
≥213 × 109/L	213	1.00 ± 0.52
PFLa			0.030
<2.9 g/L	200	0.95 ± 0.25
≥2.9 g/L	224	1.07 ± 0.55
Tumor number			0.095
Single	291	0.98 ± 0.25
Multiple	134	1.08 ± 0.68
Tumor sizea			0.378
<2 cm	124	0.98 ± 0.29
≥2 cm	299	1.02 ± 0.49
Pathological characteristics			0.156
Papilloma	27	0.94 ± 0.18
PUNLMP	67	0.931 ± 0.16
BUC	331	1.03 ± 0.48
Grade			0.836
Low-grade	180	1.03 ± 0.60
High-grade	151	1.04 ± 0.29
Stage			0.783
Ta	178	1.03 ± 0.59
T1	91	1.05 ± 0.37
T2	34	0.98 ± 0.20
T3	17	0.97 ± 0.22
T4	11	1.18 ± 0.32

Continuous variables are expressed as median ^a. Bold values are statistically significant (P < 0.05). PUNLMP: papillary urothelial neoplasm of low malignant potential; BUC: bladder urothelial carcinoma; WBC: white blood cell; PLT: platelet; PFL: plasma fibrinogen levels.